Wednesday, July 8, 2026

pharma · Unstable Angina Pectoris · Gastric Carcinoma · COLL

COLLEGIUM PHARMACEUTICAL

COLLEGIUM PHARMACEUTICAL clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

100 Technology Center Dr, Stoughton, Massachusetts 02072, US HQ
617 Employees
Public company Type
COLL · NYSE Ticker
Company details
Status
Public
HQ
100 Technology Center Dr, Stoughton, Massachusetts 02072, US
Employees
617
Programs
29
Drugs
48
Patents
28
Intelligence · Clinical Programs

COLLEGIUM PHARMACEUTICAL projects

0 ClinicalTrials.gov programs sponsored by COLLEGIUM PHARMACEUTICAL.

COLLEGIUM PHARMACEUTICAL has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does COLLEGIUM PHARMACEUTICAL have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.